Dardenne M, Pléau J M, Nabarra B, Lefrancier P, Derrien M, Choay J, Bach J F
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5370-3. doi: 10.1073/pnas.79.17.5370.
The serum thymic factor (FTS) utilized in its synthetic or natural form loses its biological activity in a rosette assay after treatment with a metal ion-chelating agent, Chelex 100. This activity is restored by the addition of Zn salts and, to a lesser extent, certain other metal salts. FTS activation is secondary to the binding of the metal to the peptide. The metal-to-peptide molar ratio of 1:1 provides the best activation. These data indicate the existence of two forms of FTS. The first one lacks Zn and is biologically inactive; the second one contains Zn and is biologically active, for which we propose the name of "thymulin" (FTS-Zn). The presence of Zn in synthetic FTS was confirmed by atomic absorption spectrometry. The interaction between Zn and FTS was further suggested by microanalysis demonstrating the presence of this metal in thymic reticuloepithelial cells.
以合成形式或天然形式使用的血清胸腺因子(FTS)在用金属离子螯合剂Chelex 100处理后,在玫瑰花结试验中失去其生物活性。通过添加锌盐以及在较小程度上添加某些其他金属盐可恢复该活性。FTS的激活继发于金属与肽的结合。金属与肽的摩尔比为1:1时激活效果最佳。这些数据表明存在两种形式的FTS。第一种缺乏锌且无生物活性;第二种含有锌且具有生物活性,我们为此提议将其命名为“胸腺生成素”(FTS-Zn)。通过原子吸收光谱法证实了合成FTS中锌的存在。微量分析表明胸腺网状上皮细胞中存在这种金属,进一步提示了锌与FTS之间的相互作用。